Can anticoagulants complement gene-editing therapies for thrombophilia, and what are the clinical implications of such combinations?
Gaurav ChauhanContributor
Can anticoagulants be used in combination with gene-editing therapies for thrombophilia?
Share
Anticoagulants may support gene-editing therapies by managing thrombosis risk during the modification of genetic factors in thrombophilia. This combination could enhance treatment efficacy and safety.